IL148234A0 - Composition for ivf - Google Patents

Composition for ivf

Info

Publication number
IL148234A0
IL148234A0 IL14823400A IL14823400A IL148234A0 IL 148234 A0 IL148234 A0 IL 148234A0 IL 14823400 A IL14823400 A IL 14823400A IL 14823400 A IL14823400 A IL 14823400A IL 148234 A0 IL148234 A0 IL 148234A0
Authority
IL
Israel
Prior art keywords
ivf
composition
phosperglycid
protein
prepared
Prior art date
Application number
IL14823400A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL148234A0 publication Critical patent/IL148234A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14823400A 1999-09-16 2000-09-11 Composition for ivf IL148234A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901308 1999-09-16
PCT/DK2000/000500 WO2001019354A2 (en) 1999-09-16 2000-09-11 Composition for ivf

Publications (1)

Publication Number Publication Date
IL148234A0 true IL148234A0 (en) 2002-09-12

Family

ID=8103409

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14823400A IL148234A0 (en) 1999-09-16 2000-09-11 Composition for ivf

Country Status (21)

Country Link
US (1) US6844313B1 (xx)
EP (1) EP1216059B1 (xx)
JP (1) JP2003509365A (xx)
KR (1) KR100757909B1 (xx)
CN (1) CN1222319C (xx)
AT (1) ATE306942T1 (xx)
AU (1) AU781994B2 (xx)
BR (1) BR0014058A (xx)
CA (1) CA2382908A1 (xx)
CZ (1) CZ2002591A3 (xx)
DE (1) DE60023324T2 (xx)
ES (1) ES2252048T3 (xx)
HU (1) HUP0202630A3 (xx)
IL (1) IL148234A0 (xx)
MX (1) MXPA02002439A (xx)
NO (1) NO323694B1 (xx)
PL (1) PL202224B1 (xx)
RU (1) RU2263516C2 (xx)
UA (1) UA78183C2 (xx)
WO (1) WO2001019354A2 (xx)
ZA (1) ZA200201383B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144529A0 (en) * 1999-02-26 2002-05-23 Novo Nordisk As Meiosis activating sterol augments implantation rate
KR100757909B1 (ko) 1999-09-16 2007-09-11 노보 노르디스크 에이/에스 Ｉｖｆ를 위한 조성물
MXPA02007818A (es) * 2000-02-25 2002-10-23 Schering Ag Tasa de implantacion mejorada utilizando ff-mas.
US6988613B2 (en) 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175074A (en) 1976-08-23 1979-11-20 Deshmukh Arvind D Serum-soluble cholesterol compounds and method for their preparation
US4751219A (en) 1985-02-05 1988-06-14 Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides
AU4312489A (en) * 1988-09-23 1990-04-18 Cetus Corporation Lipid microemulsions for culture media
DE4221880A1 (de) 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
WO1994012158A1 (en) * 1992-12-02 1994-06-09 Alkermes Controlled Therapeutics, Inc. Controlled release growth hormone containing microspheres
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
CZ279797A3 (cs) 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
CN1191543A (zh) 1995-06-23 1998-08-26 诺沃挪第克公司 减数分裂调控化合物
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media
EP0946584B1 (en) * 1996-12-20 2003-04-23 Novo Nordisk A/S Meiosis regulating compounds
EP0988312B1 (en) 1997-06-04 2002-04-03 Akzo Nobel N.V. 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
HUP9701554D0 (en) 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
KR20010043828A (ko) 1998-05-26 2001-05-25 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 ｃＡＭＰ-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법
IL144529A0 (en) * 1999-02-26 2002-05-23 Novo Nordisk As Meiosis activating sterol augments implantation rate
KR100757909B1 (ko) 1999-09-16 2007-09-11 노보 노르디스크 에이/에스 Ｉｖｆ를 위한 조성물

Also Published As

Publication number Publication date
NO20021309L (no) 2002-03-15
DE60023324D1 (de) 2005-11-24
PL353968A1 (en) 2003-12-15
KR20020032593A (ko) 2002-05-03
RU2263516C2 (ru) 2005-11-10
ES2252048T3 (es) 2006-05-16
NO323694B1 (no) 2007-06-25
BR0014058A (pt) 2004-03-30
AU6985000A (en) 2001-04-17
US6844313B1 (en) 2005-01-18
CN1373675A (zh) 2002-10-09
HUP0202630A3 (en) 2004-06-28
UA78183C2 (en) 2007-03-15
CA2382908A1 (en) 2001-03-22
DE60023324T2 (de) 2006-07-20
MXPA02002439A (es) 2002-07-30
JP2003509365A (ja) 2003-03-11
CN1222319C (zh) 2005-10-12
AU781994B2 (en) 2005-06-23
ATE306942T1 (de) 2005-11-15
NO20021309D0 (no) 2002-03-15
EP1216059A2 (en) 2002-06-26
PL202224B1 (pl) 2009-06-30
WO2001019354A3 (en) 2001-06-14
KR100757909B1 (ko) 2007-09-11
WO2001019354A2 (en) 2001-03-22
CZ2002591A3 (cs) 2002-08-14
EP1216059B1 (en) 2005-10-19
ZA200201383B (en) 2002-11-27
HUP0202630A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
HK1039942A1 (en) Piperdines as ccr5 modulators.
ID28965A (id) Azabisikloalkana sebagai modulator ccr5
AU2001239725A1 (en) Antibacterial agents
AP2001002225A0 (en) 1-heterocycle substituted diarylamines.
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
AU1482501A (en) Animal carrier
ZA200106104B (en) Pharmaceutical composition containing proton pump inhibitors.
HK1030218A1 (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same.
EP1411963A4 (en) CYTOTOXIC FACTORS FOR MODULATING CELL DEATH
TW200640505A (en) Device comprising VGF polypeptides
AU9534398A (en) Novel pharmaceutical composition
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
ZA200006463B (en) Composition for keeping away vermin.
AP2001002220A0 (en) Calcilytic compounds.
MY124078A (en) Eletriptan hydrobromide monohydrate
AU7978000A (en) Indium-enhanced bipolar transistor
GB9907571D0 (en) Compounds
GB2348558A8 (en) GPS for workstations
IL148234A0 (en) Composition for ivf
CA2268796A1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
EP1278520A4 (en) DIARYLE PIPERIDYL PYRROLE DERIVATIVES AS ANTIPROTOZOAL AGENTS
HUP0202652A3 (en) Pharmaceutical carrier composition
AU3455000A (en) Composition for decomposing protein